CD200R1 Agonist Attenuates Mechanisms of Chronic Disease in a Murine Model of Multiple Sclerosis

To assess the effects and mechanisms of a CD200R1 agonist administered during the progressive stage of a multiple sclerosis model, we administered CD200R1 agonist (CD200Fc) or control IgG2a during the chronic phase of disease (days 10–30) in mice with experimental autoimmune encephalomyelitis (EAE),...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Liu, Yingru, Bando, Yoshio, Vargas-Lowy, David, Elyaman, Wassim, Khoury, Samia J., Huang, Tao, Reif, Karin, Chitnis, Tanuja
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Society for Neuroscience 2010
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2837938/
https://ncbi.nlm.nih.gov/pubmed/20147531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.4272-09.2010
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak